2016
DOI: 10.1093/cid/ciw425
|View full text |Cite
|
Sign up to set email alerts
|

A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase–Producing Organism

Abstract: Our findings suggest that a clinical decision tree can be used to estimate a bacteremic patient's likelihood of infection with ESBL-producing bacteria. Recursive partitioning offers a practical, user-friendly approach for addressing important diagnostic questions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
98
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 153 publications
(104 citation statements)
references
References 31 publications
5
98
0
1
Order By: Relevance
“…This risk can be assessed based on several prediction models developed to help healthcare providers estimate the likelihood of infection with ESBL‐producing organisms using patient‐specific risk factors, like prior antibiotic exposure. Stratification of patients is crucial as the non‐stratified use of carbapenems is not justified and will only lead to further antimicrobial resistance . Piperacillin‐tazobactam is a possible choice but covers only 80% of the Enterobacteriaceae and 94% of the E. coli .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This risk can be assessed based on several prediction models developed to help healthcare providers estimate the likelihood of infection with ESBL‐producing organisms using patient‐specific risk factors, like prior antibiotic exposure. Stratification of patients is crucial as the non‐stratified use of carbapenems is not justified and will only lead to further antimicrobial resistance . Piperacillin‐tazobactam is a possible choice but covers only 80% of the Enterobacteriaceae and 94% of the E. coli .…”
Section: Discussionmentioning
confidence: 99%
“…Stratification of patients is crucial as the non-stratified use of carbapenems is not justified and will only lead to further antimicrobial resistance. 20,21 Piperacillin-tazobactam is a possible choice but covers only 80% of the those who used aminoglycosides. 25 Aminoglycosides have been tried also for antibiotic prophylaxis.…”
Section: Timely Administration Of Adequate Empirical Antibiotics Whenmentioning
confidence: 99%
“…One of the global challenges that face mankind is the evolution of carbapenem-resistant enterobacteriaceae (CRE), as carbapenem antibiotics are considered a “last-resort” antibiotic [1,2]. With CRE blood infections, the mortality rate increases at about 8% for each hour of delay in obtaining a correct diagnosis and appropriate antibiotic treatment [3,4].…”
Section: Introductionmentioning
confidence: 99%
“…Better prediction rules for infections caused by antibiotic-resistant pathogens are therefore needed. Prediction systems have been developed for Gram-negative bacteraemia in septic patients [24], carriage of or infection with ESBL-producing Enterobacteriaceae at hospital admission [1,25,26], and distinguishing bacteraemia with ESBL- or carbapenemase-producing pathogens from bacteraemia with susceptible Enterobacteriaceae [58].…”
Section: Discussionmentioning
confidence: 99%
“…Hence, patients and physicians might benefit from prediction rules for 3GC-R EB. Although risk factors for carriage of ESBL-producing Enterobacteriaceae at hospital admission [14], and factors distinguishing ESBL- and carbapenemase-producing Enterobacteriaceae as a cause of bacteraemia have been determined [58], there are no prediction rules for identifying 3GC-R EB as a cause of bacteraemia at the time that empiric therapy must be started.…”
Section: Introductionmentioning
confidence: 99%